HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nonprofit Pharmaceutical Companies

532.388

+13.1152.53%

Number of Gainers:25

Number of Losers:5

Number of Flat:3

PE:- -

High:536.046

Open:518.785

Low:509.785

Close:519.273

Volume:108.28M

Turnover:3.89B

Market Cap:337.79B

Float Cap:301.32B

Loading ...

Insilico Medicine Shares Surge Nearly 8% as AI Drug Discovery Sector Continues to Heat Up, Company's BD and PCC Output Hit Record Highs

Hong Kong Stock Movers: mRNA Concept Stocks Lead Gains, CanSinoBIO (06185) Surges Over 17% as Moderna's mRNA Neoantigen Therapy Set to Debut at ESMO Congress

Hong Kong Stock Market Commentary: Housing Interest Subsidy Boosts Property Stocks, Innovative Drugs See Dense Catalysts

Ourea Biotech HK Limited Sells 6 Million Shares of GenFleet-B (02595) at HK$27.3 Each

Hong Kong Stock Connect Innovative Drug Sector Defies Market Downturn as Top Pharmaceutical Firm Enters with US$2 Billion, Akeso Surges 15.54%, Hengrui Pharma Secures US$2.6 Billion BD Deal

Yahong Meditech (688176.SH) Plans 2026 Employee Stock Ownership Plan

Multiple Positive Catalysts Converge: Are Innovative Drugs Still the Focus for the Fourth Quarter?

Zai Lab to Present First Global Data on DLL3 ADC Zocilurtatug Pelitecan in First-Line ES-SCLC Trial at ESMO 2026

Zai Lab to Present First Global Data from Clinical Trial Evaluating Zocilurtatug Pelitecan (Zoci) as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer (Es-Sclc)

THOMSON REUTERS

EDDING GENOR (06998) Spends HK$1.6999 Million to Repurchase 1 Million Shares on September 29

China's BioDlink International HY Revenue Falls

Shenzhen Lifotronic Technology Secures Medical Device Registration Certificate for Photon Therapeutic Apparatus

Biodlink International Co H1 Revenue RMB 246.011 Million

THOMSON REUTERS

ZYLOXTB Spends HK$1.1383 Million to Repurchase 53,000 Shares on September 29

Hong Kong Stocks Slip as Property and Biotech ETF Sectors Rally on Policy Signals

AH Premium Statistics for September 29

China Innovation Drug ETF (03525) Rises Over 2%, Focusing on R&D-Driven Quality Innovative Drug Companies in Hong Kong and Developed Markets

CStone Pharma-B (02616) Jumps Nearly 7% as ESMO Data Update Nears and Executive's Continued Share Purchases Signal Confidence in Growth

Keymed Bio-B Jumps Over 9% in Afternoon Trading, Company Holds Strong Competitive Edge Across Multiple Innovative Drug Areas Including Autoimmune and Oncology

Ascletis Pharma Reports Positive Results From ASC50 Psoriasis Trial

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/BK1574/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"Nonprofit Pharmaceutical Companies","latestPrice":532.3884,"timestamp":1790755705764,"preClose":519.27344,"halted":0,"volume":108281314,"delay":0,"changeRate":0.025256,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed National Day","change":13.11499,"latestTime":"09-30 16:00:00","open":518.7852,"high":536.04626,"low":509.7852,"amount":3894467673,"amplitude":0.050573,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1790904600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1790731800000,1790740800000],[1790744400000,1790755200000]],"pbRate":3.863573,"peRate":171.860059,"turnoverRate":0.003973,"increases":27,"decrements":4,"flats":1,"marketCap":337786113504,"floatMarketCap":301319866336},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":536.04626,"amplitude":0.050573,"preClose":519.27344,"low":509.7852,"pbRate":"3.863573","latestPrice":532.3884,"volume":108281314,"delay":0,"open":518.7852,"prevYearClose":556.26263,"prevWeekClose":495.27,"prevMonthClose":532.388,"prevQuarterClose":532.388,"fiveDayClose":520.692,"twentyDayClose":501.553,"sixtyDayClose":496.318,"secType":"PLATE","market":"HK","turnoverRate":0.003973,"peRate":171.860059,"marketCap":337786113504,"floatMarketCap":301319866336,"timestamp":1790755705764,"nameCN":"Nonprofit Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":25,"down":5,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1181481190","title":"Insilico Medicine Shares Surge Nearly 8% as AI Drug Discovery Sector Continues to Heat Up, Company's BD and PCC Output Hit Record Highs","url":"https://stock-news.laohu8.com/highlight/detail?id=1181481190","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181481190?lang=en_us&edition=fundamental","pubTime":"2026-09-30 10:08","pubTimestamp":1790734096,"startTime":"0","endTime":"0","summary":"Insilico Medicine (03696) rose nearly 8%, up 7.85% as of press time to HK$59.75, with turnover of HK$363 million.On the news front, as of the latest data, Insilico Medicine has disclosed a total...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","VTHR","AIPO","VXUS","KCAI","AGIX","BK4585","01477","BK1141","CHAT","BK4588","03696","ARTY","QTOC","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154987922","title":"Hong Kong Stock Movers: mRNA Concept Stocks Lead Gains, CanSinoBIO (06185) Surges Over 17% as Moderna's mRNA Neoantigen Therapy Set to Debut at ESMO Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=1154987922","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154987922?lang=en_us&edition=fundamental","pubTime":"2026-09-30 10:02","pubTimestamp":1790733739,"startTime":"0","endTime":"0","summary":"mRNA concept stocks are leading the gains, with CanSinoBIO (06185) rising 16.78% to HK$36.32 as of press time.Everest Medicines (01952) is up 4.29% at HK$29.18, 3D Medicines (01244) has gained 1.94%...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXUS","BK1161","07666","BK1191","KCAI","BK1583","01244","01952","BK1574","06185","BK4585","BK4588","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161134760","title":"Hong Kong Stock Market Commentary: Housing Interest Subsidy Boosts Property Stocks, Innovative Drugs See Dense Catalysts","url":"https://stock-news.laohu8.com/highlight/detail?id=1161134760","media":"Stock News","labels":["economic"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161134760?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:30","pubTimestamp":1790685036,"startTime":"0","endTime":"0","summary":"Dissecting the Market: Before the holiday, various funds are engaging in all sorts of maneuvering. A-shares fell heavily over the past two days but finally rebounded today, while Hong Kong stocks...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159992","01081","SG9999003461.SGD","KCAI","02128","BK4585","LU0082770016.SGD","BK1506","IE0008368742.USD","LNGR","BK1240","LU0052750758.USD","SGXZ62798434.SGD","VXUS","BK1161","LU1808992512.USD","IE00B031HY20.USD","03393","BK1205","BK4588","LU0620787316.HKD","MEDX","BK1529","03996","LU0708995583.HKD","BK1574","BK1179","LU0082770016.USD","SG9999002950.SGD","SG9999001069.SGD","BK1105","SG9999014674.SGD","BK1555","SGXZ86797644.SGD","IE0008369823.USD","03301","LU0320764599.SGD","IBBQ","LU0164939612.USD","00552","BK1148","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198747120","title":"Ourea Biotech HK Limited Sells 6 Million Shares of GenFleet-B (02595) at HK$27.3 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=1198747120","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198747120?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:28","pubTimestamp":1790681297,"startTime":"0","endTime":"0","summary":"According to the latest data from the Hong Kong Stock Exchange, on September 24, Ourea Biotech HK Limited reduced its holdings in GenFleet-B (02595) by 6 million shares at a price of HK$27.3 per...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","EWH","02595","BK4588","XBI","BK4581","09939","159938","BK4585","BK1515","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173705860","title":"Hong Kong Stock Connect Innovative Drug Sector Defies Market Downturn as Top Pharmaceutical Firm Enters with US$2 Billion, Akeso Surges 15.54%, Hengrui Pharma Secures US$2.6 Billion BD Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=1173705860","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173705860?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:20","pubTimestamp":1790680850,"startTime":"0","endTime":"0","summary":"On September 29, the Hong Kong stock market retreated, but innovative drugs led gains against the broader trend. The Hang Seng Stock Connect Innovative Drug ETF (520880) tracking index, with 100%...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1023057109.AUD","IE00BPRC5H50.USD","LU1794554557.SGD","LU2476274720.SGD","BK1161","LU0348767384.USD","LU1328615791.USD","FLHK","LU1064130708.USD","LU0540923850.HKD","LU1820825898.SGD","LU0348827113.USD","LU2778985437.USD","01276","LU0405327148.USD","LU2328871848.SGD","LU0359202008.SGD","LU0561508036.HKD","159992","LU0348766576.USD","BK0188","LU2289578879.USD","LU0417516902.SGD","LU1781817850.SGD","IE00B5MMRT66.SGD","LU1961090484.USD","LU0359201612.USD","LU2399975544.HKD","LU1255011170.USD","MEDX","BK1574","LU2097828474.EUR","LU2097828805.USD","LU2097828557.USD","LU2148510915.USD","LU2488822045.USD","06978","LNGR","LU1580142542.USD","LU0348825331.USD","LU2476274308.USD","09926","BK0183","KURE","LU0348783233.USD","LU0359201885.HKD","BK0060","IBBQ","BK0028","LU0348784397.USD","LU2097828631.EUR","LU2097828714.EUR","LU0634319403.HKD","LU2580892862.HKD","LU1720050803.USD","LU0405327494.USD","LU0348735423.USD","BK1191","LU1146622755.USD","LU1997245094.SGD","LU1064131003.USD","LU1997245177.USD","LU2543165471.USD","IE00B543WZ88.USD","BK0196","LU1969619763.USD","LU2495084118.USD","BK0239","BK0012","600276","LU1655091616.SGD","LU0417516738.SGD","LU2580892789.USD","LU1997244956.HKD","LU0417516571.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133216681","title":"Yahong Meditech (688176.SH) Plans 2026 Employee Stock Ownership Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=1133216681","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133216681?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:18","pubTimestamp":1790680710,"startTime":"0","endTime":"0","summary":"Yahong Meditech (688176.SH) has released a draft of its 2026 employee stock ownership plan, according to an announcement.Upon approval by the company's shareholders' meeting, the plan will acquire...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","688176","BK1574","09939","BK1515","BK0239","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110462263","title":"Multiple Positive Catalysts Converge: Are Innovative Drugs Still the Focus for the Fourth Quarter?","url":"https://stock-news.laohu8.com/highlight/detail?id=1110462263","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110462263?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:10","pubTimestamp":1790680230,"startTime":"0","endTime":"0","summary":"Positive developments across policy, industry, pharmaceutical companies, AIDD, and corporate performance are resonating together.Is innovative drugs still the key theme to watch in the fourth...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","IBBQ","MEDX","BK1574","159992","BK1161","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671215090","title":"Zai Lab to Present First Global Data on DLL3 ADC Zocilurtatug Pelitecan in First-Line ES-SCLC Trial at ESMO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2671215090","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671215090?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:01","pubTimestamp":1790679688,"startTime":"0","endTime":"0","summary":"Zai Lab to present first global data on DLL3 ADC zocilurtatug pelitecan in first-line ES-SCLC trial at ESMO 2026Zai Lab flagged first global results from a trial of zocilurtatug pelitecan for first-li","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDL8p8mnn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09688","BK1588","LU2488822045.USD","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671721575","title":"Zai Lab to Present First Global Data from Clinical Trial Evaluating Zocilurtatug Pelitecan (Zoci) as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer (Es-Sclc)","url":"https://stock-news.laohu8.com/highlight/detail?id=2671721575","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671721575?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:00","pubTimestamp":1790679602,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUA6R3CVM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["09688","LU2488822045.USD","BK1574","BK1588","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121622936","title":"EDDING GENOR (06998) Spends HK$1.6999 Million to Repurchase 1 Million Shares on September 29","url":"https://stock-news.laohu8.com/highlight/detail?id=1121622936","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121622936?lang=en_us&edition=fundamental","pubTime":"2026-09-29 18:50","pubTimestamp":1790679009,"startTime":"0","endTime":"0","summary":"EDDING GENOR (06998) announced that on September 29, 2026, the company spent HK$1.6999 million to repurchase 1 million shares, at a repurchase price of HK$1.695 to HK$1.7 per share.","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1161","06998","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671229065","title":"China's BioDlink International HY Revenue Falls","url":"https://stock-news.laohu8.com/highlight/detail?id=2671229065","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671229065?lang=en_us&edition=fundamental","pubTime":"2026-09-29 17:29","pubTimestamp":1790674167,"startTime":"0","endTime":"0","summary":"China's BioDlink International HY revenue fallsOverviewChina CDMO provider's half-year revenue fell to RMB 246 blnCompany expanded CDMO operations and invested in R&D during the reporting periodWuXi X","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nL1N45L09P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","01875","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101970069","title":"Shenzhen Lifotronic Technology Secures Medical Device Registration Certificate for Photon Therapeutic Apparatus","url":"https://stock-news.laohu8.com/highlight/detail?id=1101970069","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101970069?lang=en_us&edition=fundamental","pubTime":"2026-09-29 17:29","pubTimestamp":1790674165,"startTime":"0","endTime":"0","summary":"Shenzhen Lifotronic Technology Co.,Ltd. (688389.SH) has announced that its controlling subsidiary, Chongqing Lifotronic Biotechnology Co., Ltd., recently received the Medical Device Registration...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09996","BK1574","IEIH","LNGR","BK1100","AGNG","BK1583","LGHT","MDEV","MEDX","PTH","RSPH","159883","GDOC","BK0251","HART","688389"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671029702","title":"Biodlink International Co H1 Revenue RMB 246.011 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2671029702","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671029702?lang=en_us&edition=fundamental","pubTime":"2026-09-29 17:18","pubTimestamp":1790673528,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nPLXMLCG4P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01875","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111891998","title":"ZYLOXTB Spends HK$1.1383 Million to Repurchase 53,000 Shares on September 29","url":"https://stock-news.laohu8.com/highlight/detail?id=1111891998","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111891998?lang=en_us&edition=fundamental","pubTime":"2026-09-29 16:58","pubTimestamp":1790672320,"startTime":"0","endTime":"0","summary":"ZYLOXTB (02190) has announced that on September 29, 2026, the company spent HK$1.1383 million to repurchase 53,000 shares, with a repurchase price ranging from HK$21.36 to HK$21.54 per share.","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","BK1583","02190","BK1100","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113675289","title":"Hong Kong Stocks Slip as Property and Biotech ETF Sectors Rally on Policy Signals","url":"https://stock-news.laohu8.com/highlight/detail?id=1113675289","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113675289?lang=en_us&edition=fundamental","pubTime":"2026-09-29 16:43","pubTimestamp":1790671392,"startTime":"0","endTime":"0","summary":"Hong Kong's three major indices closed slightly lower today, with heavyweight technology stocks weakening and structural divergence across the board standing out, while mainland property and...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","159992","BK4588","LNGR","06978","BK1161","BK4550","FDN","IBBQ","BK1574","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140639624","title":"AH Premium Statistics for September 29","url":"https://stock-news.laohu8.com/highlight/detail?id=1140639624","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140639624?lang=en_us&edition=fundamental","pubTime":"2026-09-29 16:21","pubTimestamp":1790670095,"startTime":"0","endTime":"0","summary":"As of the market close on September 29, NE ELECTRIC (00042), ZHEJIANG SHIBAO (01057), and HOLLY FUTURES (03678) ranked as the top three stocks by AH premium rate, with premium rates of 1155.81%,...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1564","LU0449509016.USD","BK1149","LU0918141705.HKD","SG9999006597.SGD","LU1988902786.USD","LU0797268264.HKD","00553","03678","LU0463099449.HKD","LU0979878070.USD","EWH","BK1116","LU0828238088.HKD","LU1206782309.USD","LU2476274720.SGD","LU0348825331.USD","03750","LU0164880469.USD","LU1880383440.USD","LU0543330483.HKD","LU1303224171.USD","LU0531970944.HKD","LU2226246903.HKD","LU0214875030.USD","BK1190","LU0431992006.USD","LU0164939612.USD","LU2045819591.USD","BK1231","LU1064131342.USD","03188","HK0000306685.HKD","LU0640798160.USD","LU1048596156.SGD","LU1366334578.USD","LU1282648689.USD","LU1242518931.SGD","BK1521","LU0051755006.USD","LU1282649810.SGD","LU0327786744.USD","06951","LU0328353924.USD","LU0648948544.HKD","LU0345780521.USD","LU1226287529.USD","LU0348766576.USD","LU1282649141.HKD","LU1188198961.HKD","LU0588546209.SGD","LU0456854461.SGD","IE00BZ08YR35.GBP","LU1244550494.USD","IE00BMCWC346.EUR","BK1191","LU0791591158.USD","LU0456827905.SGD","SG9999002463.SGD","LU1244550221.USD","83188","LU0329678170.USD","BK1583","01812","LU1880383366.USD","LU1224709979.USD","IE00BZ08YS42.EUR","LU0516423174.USD","00187","LU0320764755.SGD","LU0886674414.USD","IE00B3M56506.USD","SG9999002828.SGD","LU1255011170.USD","LU1993786604.SGD","BK1119","HK0001040143.USD","LU0315179316.USD","00568","LU0348814723.USD","02701","LU0228367735.SGD","BK1249","LU0634319403.HKD","LU1675838814.USD","LU0821914370.USD","LU0329678337.USD","LU0210526637.USD","LU0164865239.USD","BK1170","LU1770034418.SGD","LU0348805143.USD","02822","BK1551","BK1539","BK1171","LU0516422952.EUR","HK0000306701.USD","LU0456846285.SGD","IE00B031HY20.USD","LU0173614495.USD","IE00BVYPNQ40.USD","LU0067412154.USD","02827","IE00BF5LJ272.USD","LU0593848301.USD","03968","LU0868486357.SGD","LU0106252389.USD","LU1808992512.USD","LU3063872942.SGD","LU2778985437.USD","06821","LU0455707207.USD","IE00BGHQDM52.EUR","02865","BK1574","IE0008368742.USD","02359","BK1522","LU1720050803.USD","LU0501845795.SGD","LU1688375341.USD","LU0181495838.USD","06185","BK1193","LU2097828805.USD","BK1515","LU0348735423.USD","LU0345780281.USD","LU0029875118.USD","IE00B5MMRT66.SGD","LU0620787316.HKD","399300","LU2097828474.EUR","02899","03130","LU1366334651.USD","LU1211504680.USD","LU1008478684.HKD","01057","LU0509642566.USD","SG9999001226.SGD","LU1807302812.USD","BK1161","LU0384037296.USD","LU0244354667.USD","LU0052750758.USD","BK1148","LU2039709279.SGD","00991","02843","IE0034224299.USD","BK1125","SG9999001093.SGD","BK1594","LU2177674079.SGD","LU0348788117.USD","BK1562","03143","LU2097828714.EUR","LU0417516902.SGD","LU0488056044.USD","LU0140636845.USD","LU0061477393.USD","HK0000352382.USD","BK1514","LU0287142896.SGD","LU2264538146.SGD","HK0001040168.HKD","BK1533","LU0231483743.USD","LU0314109678.HKD","LU2008162690.USD","02823","LU2476274308.USD","LU1769817096.USD","06127","01033","LU0359202008.SGD","LU1242518857.USD","LU0502904849.HKD","LU0096374516.USD","BK1122","BK1554","02691","LU0149721374.USD","LU0469268626.HKD","LU0326950275.SGD","LU0082770016.SGD","BK1147","BK1505","LU0540923850.HKD","BK1130","LU0128522157.USD","LU2125910500.SGD","03996","LU0672654166.SGD","LU0890818403.SGD","LU0082770016.USD","02338","01108","LU0228659784.USD","LU0266512127.USD","SG9999014674.SGD","IE00B031J352.USD","LU0516422440.USD","LU0320764599.SGD","02846","IE00BVYPNP33.GBP","LU0589944569.HKD","LU0307460666.USD","159982","00042","09976","BK1183","LU0828237940.HKD","HK0000320264.USD","LU0823426308.USD","LU1328277881.USD","00811","LU1960683339.HKD","LU1831875114.USD","LU0572944931.SGD","LU0269904917.USD","BK1530","BK1592","LU1046422090.SGD","LU0561508036.HKD","BK1163","BK1544","BK1507","LU0823426480.USD","LU0049853897.USD","LU0607220059.USD","LU1244550577.SGD","LU1115378108.SGD","BK1181","LU0871576103.HKD","82846","LU0266512473.USD","IE00BZ08YT58.USD","IE0008369823.USD","BK1576","LU0039217434.USD","LU0149534421.HKD","03986","BK1141","BK1610","LU1152091168.USD","LU1282649067.USD","LU2097828557.USD","BK1144","LU0862451753.SGD","LU0880133367.SGD","LU1719994722.HKD","82822","01349","83130","LU2294711473.HKD","IE0032431581.USD","LU0348827113.USD","LU0348767384.USD","07233","LU0117841782.USD","LU1481107354.HKD","02475","LU0048580855.USD","82823","BK1223","LU0791590937.USD","LU1769817179.HKD","LU0106959298.USD","LU0043850808.USD","LU0516423091.SGD","BK1237","LU0543330566.HKD","LU0348816934.USD","LU1794554557.SGD","LU1655091616.SGD","82843","LU2399975544.HKD","LU0918141887.USD","SG9999011746.SGD","LU1504937902.USD","IE00BYV24P56.USD","03200","LU1251922891.USD","LU1961090484.USD","LU0516422366.SGD","LU1023057109.AUD","LU0165289439.USD","03228","LU2097828631.EUR","IE00B29SXG58.USD","LU0531971595.HKD","LU0254981946.USD","LU0163747925.USD","02218","BK1560","LU0359201612.USD","LU0417516738.SGD","LU0737861772.HKD","BK1105","IE00B543WZ88.USD","LU1813983027.USD","HK0000352291.HKD","LU1105468828.SGD","LU0370786039.SGD","LU1152091754.HKD","LU0359201885.HKD","LU0828237510.HKD","HK0000320223.HKD","SG9999004220.SGD","BK1202","03308","IE0031814852.USD","LU0708995583.HKD","LU2242644610.SGD","03328","LU0211977185.USD","BK1110","LU0229945570.USD","BK1546","06067","02238","LU0072913022.USD","LU0737861699.HKD","BK1198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113085280","title":"China Innovation Drug ETF (03525) Rises Over 2%, Focusing on R&D-Driven Quality Innovative Drug Companies in Hong Kong and Developed Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=1113085280","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113085280?lang=en_us&edition=fundamental","pubTime":"2026-09-29 15:22","pubTimestamp":1790666534,"startTime":"0","endTime":"0","summary":"According to Zhitong Finance APP, China Innovation Drug ETF (03525) rose over 2%, reaching 2% as of press time, at HK$10.2, with a turnover of HK$491,300.It is reported that the China Innovation Drug...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","159992","BK1161","WSGE","03525","BK4585","06978","MEDX","BK4550","BK4588","FDN","LNGR","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172233611","title":"CStone Pharma-B (02616) Jumps Nearly 7% as ESMO Data Update Nears and Executive's Continued Share Purchases Signal Confidence in Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=1172233611","media":"Stock News","labels":["executive","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172233611?lang=en_us&edition=fundamental","pubTime":"2026-09-29 14:10","pubTimestamp":1790662217,"startTime":"0","endTime":"0","summary":"According to Zhitong Finance APP, CStone Pharma-B (HKEX: 02616) rose nearly 7%, up 6.81% as of press time to HK$5.49, with turnover of HK$35.1891 million.On the news front, the latest clinical data...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02616","BK4585","BK1161","KCAI","VXUS","BK1574","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110569578","title":"Keymed Bio-B Jumps Over 9% in Afternoon Trading, Company Holds Strong Competitive Edge Across Multiple Innovative Drug Areas Including Autoimmune and Oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=1110569578","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110569578?lang=en_us&edition=fundamental","pubTime":"2026-09-29 13:50","pubTimestamp":1790661039,"startTime":"0","endTime":"0","summary":"Keymed Bio-B (02162) rose more than 8% in afternoon trading, climbing 8.95% as of press time to HKD 79.70, with a turnover of HKD 237 million.Earlier this month, Keymed Bio-B (02162) announced that...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159992","BK1574","BK1583","MEDX","LNGR","02162","BK1161","IBBQ","06978","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671293640","title":"Ascletis Pharma Reports Positive Results From ASC50 Psoriasis Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2671293640","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671293640?lang=en_us&edition=fundamental","pubTime":"2026-09-29 13:39","pubTimestamp":1790660392,"startTime":"0","endTime":"0","summary":"Ascletis Pharma  said its oral small-molecule IL-17A inhibitor ASC50 showed positive results in a 28-day proof-of-concept clinical trial in the U.S. for patients with mild-to-moderate plaque psoriasis, according to a Tuesday filing with the Hong Kong bourse.The once-daily 200 mg treatment achieved a 48.9% placebo-adjusted reduction in psoriasis area and severity index, or PASI, score after 28 days.The reduction increased to 60.7% six days after the final dose and 65.9% 15 days after the final dose, the filing said.The treatment was safe and well tolerated, with all adverse events reported as mild and transient.Shares of the pharmaceutical firm were down nearly 2% in Tuesday morning trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1515","BK1161","01672","BK1574"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":11,"pageCount":2,"totalSize":206,"code":"91000000","status":"200"}]}}